PAK4 and neoplasm: In human glioblastomas, PAK4 reduces the expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) via SLUG, thereby diminishing T cell adhesion to tumor endothelial cells.